| Alport Foundation Awards $100K to Study Rare Kidney Disease - Renal Business Today |
|
|
Renal Business Today Perin recently discovered evidence suggesting that a single injection of AFSCs has the capacity to reduce fibrosis, accompanied with an overall improvement of renal function and lifespan in mice. Understanding how AFSCs behave in an in vivo environment |